{
    "organizations": [],
    "uuid": "5a190c86ae82fd15c9bd8c148be1879a6b9eaf4e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-menlo-therapeutics-reports-q4-loss/brief-menlo-therapeutics-reports-q4-loss-of-1-80-per-share-idUSASC09U21",
    "ord_in_thread": 0,
    "title": "BRIEF-Menlo Therapeutics Reports Q4 Loss Of $1.80 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - Menlo Therapeutics Inc:\n* MENLO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* MENLO THERAPEUTICS INC QUARTERLY LOSS PER SHARE $1.80 * MENLO THERAPEUTICS INC QUARTERLY COLLABORATION AND LICENSE REVENUE $2.8 MILLION VERSUS $450,000 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-03-29T04:15:00.000+03:00",
    "crawled": "2018-03-29T16:08:48.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "menlo",
        "therapeutic",
        "inc",
        "menlo",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "menlo",
        "therapeutic",
        "inc",
        "quarterly",
        "loss",
        "per",
        "share",
        "menlo",
        "therapeutic",
        "inc",
        "quarterly",
        "collaboration",
        "license",
        "revenue",
        "million",
        "versus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}